Trials / Conditions / Factor VII Deficiency
Factor VII Deficiency
7 registered clinical trials studyying Factor VII Deficiency — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (P NCT06349473 | Equilibra Bioscience LLC | Phase 1 |
| Completed | A Phase I of SS109 in Hemophilia A or and B With Inhibitors NCT05651061 | Jiangsu Gensciences lnc. | Phase 1 |
| Terminated | Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders NCT04548791 | Catalyst Biosciences | Phase 1 / Phase 2 |
| Enrolling By Invitation | Early Check: Expanded Screening in Newborns NCT03655223 | RTI International | — |
| Completed | Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Fa NCT03079063 | AryoGen Pharmed Co. | Phase 3 |
| Completed | Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven NCT03372993 | AryoGen Pharmed Co. | — |
| Completed | Treatment of Inherited Factor VII Deficiency NCT01269138 | University of L'Aquila | — |